|
FAU expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.96300000002248E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.09589999999871E-05 |
| Normal-vs-Stage2 |
4.148300E-02 |
| Normal-vs-Stage3 |
7.375900E-03 |
| Normal-vs-Stage4 |
2.21889999999503E-05 |
| Stage1-vs-Stage2 |
6.588200E-01 |
| Stage1-vs-Stage3 |
8.391200E-01 |
| Stage1-vs-Stage4 |
1.724360E-01 |
| Stage2-vs-Stage3 |
6.156000E-01 |
| Stage2-vs-Stage4 |
1.118200E-01 |
| Stage3-vs-Stage4 |
2.807200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.27139999997572E-06 |
| Normal-vs-AfricanAmerican |
2.183300E-03 |
| Normal-vs-Asian |
1.486210E-01 |
| Caucasian-vs-AfricanAmerican |
7.148000E-01 |
| Caucasian-vs-Asian |
2.539400E-01 |
| AfricanAmerican-vs-Asian |
2.910200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64333999999045E-05 |
| Normal-vs-Female |
4.216500E-04 |
| Male-vs-Female |
5.993200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.74469999999883E-05 |
| Normal-vs-Extreme_Weight |
5.84260000047188E-07 |
| Normal-vs-Obese |
8.439500E-04 |
| Normal-vs-Extreme_Obese |
4.237000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.256400E-01 |
| Normal_Weight-vs-Obese |
2.230200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.291200E-01 |
| Extreme_Weight-vs-Obese |
2.613600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.196950E-01 |
| Obese-vs-Extreme_Obese |
3.714800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.784530E-03 |
| Normal-vs-Age(41-60Yrs) |
9.86400000000387E-05 |
| Normal-vs-Age(61-80Yrs) |
3.52369999999658E-05 |
| Normal-vs-Age(81-100Yrs) |
1.408020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.540300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.158560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.910550E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.931200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.725800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.591600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.68239999995568E-06 |
| Normal-VS-Type2 PRCC |
1.280300E-02 |
| Normal-VS-KIRP CIMP |
5.058000E-03 |
| Normal-VS-Unclassified PRCC |
6.618000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.456200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.387600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.744000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.596400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.749400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.063700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.70479999999885E-05 |
| Normal-vs-N1 |
1.036990E-03 |
| Normal-vs-N2 |
1.917030E-01 |
| N0-vs-N1 |
9.258800E-01 |
| N0-vs-N2 |
6.806800E-01 |
| N1-vs-N2 |
6.917200E-01 |
|
|
